Be prepared before traveling to China for CAR T-cell therapy.
CAR T-cell therapy, is an advanced form of immunotherapy that involves modifying a patient’s own T-cells to better recognize and attack cancer cells. It is especially effective in treating blood cancers, such as multiple myeloma, leukemia and lymphoma. This innovative treatment has seen significant advancements globally, including in China, where the healthcare system and research institutions are rapidly adopting cutting-edge medical technologies. Treatment with CAR T-cell therapy involves the following steps:
Apheresis is the process of collecting a patient’s T cells, a type of immune cell. During this procedure, blood is drawn from the patient, and a machine separates the T cells from the rest of the blood. The remaining components are then returned to the patient’s body. The T cells are extracted through a tube inserted into a vein in the arm, and the entire process typically takes a couple of hours.
In the lab, T cells are genetically altered to display a Chimeric Antigen Receptor (CAR) on their surface. This CAR is designed to recognize and bind to specific proteins, or antigens, that are present on the surface of cancer cells.
The genetically modified T cells are then cultured and expanded, leading to a large population of CAR T cells. This process ensures there are sufficient modified T cells available for effective treatment.
Before receiving the CAR T-cell infusion, patients often undergo a conditioning treatment, which may involve low-dose chemotherapy or radiation. This treatment helps create an environment that supports the multiplication and function of the newly infused CAR T cells within the patient’s body.
Once ready, the CAR T cells are infused back into the patient’s bloodstream through an intravenous drip. The infused cells then circulate throughout the body, locating and binding to cancer cells that express the targeted antigen.
When a CAR T cell encounters a cancer cell displaying the targeted antigen, it binds to the cancer cell. This interaction activates the CAR T cell, triggering it to release molecules that destroy the cancer cell.
Patients are closely monitored for signs of response, such as a reduction in tumor size. The effectiveness of CAR T-cell treatment is assessed through various imaging techniques and laboratory tests.
Some patients may experience cytokine release syndrome (CRS) or neurotoxicity, both of which are carefully monitored by healthcare professionals.
CAR T-cell therapy is a highly effective method in the treatment of lymphoma, leukemia and multiple myeloma. Contact us and get detailed information about CAR T-cell therapies provided for you or your loved one.
Send the following reports including medical summary, biopsy, latest blood reports, PET scan report to info@tcellschina.com or Whatsapp us at +86 13578917711.
An expert will go through your reports and provide suggestions for your particular condition. If you wish to talk to the doctor, an online consultation session can be scheduled.
Once you decide to proceed with the treatment, we will arrange a medical visa letter and any other required documents from the hospital. Once your visa is approved, we will assist you with travel preparations and help you with booking your flight tickets.
Our representative will assist in handling all the necessary registration procedures. They will also support you with hospital admission and provide any local assistance you may need. Once your treatment is complete, we will arrange a follow-up consultation with the attending doctor.
China has established itself as a global leader in the advancement of CAR T-cell therapy, with a significant number of activities dedicated to its development and research. Rigorous manufacturing and treatment guidelines have been put in place to guarantee the safety and quality of these therapies. As of September 2024, six CAR T-cell therapy products have been approved following successful completion of phase I, II, and III clinical trials, demonstrating promising results.
Beyond the effectiveness of these CAR T-cell therapies, patient-friendly pricing strategies are employed in the country to enhance the accessibility and affordability of this groundbreaking technology.
China has made significant strides in medical care and research, including advancements in CAR T-cell therapy.
China’s rapid advancements in biotechnologies are establishing it as a leader in CAR T-cell therapy, ensuring effective treatments.
China offers effective CAR T-cell therapies and other medical services with patient-friendly pricing and an accessible approach.
Our devoted service team is with you every step of the way during the CAR T-cell treatment, providing support as you combat cancer.
Whether you’re a patient, caregiver, or medical professional, our team can connect you with leading CAR-T treatment centers and clinical experts in China.
Fill out the form below and we’ll get back to you shortly with personalized support.